Overview
Study to Compare the Efficacy and Safety of Pitavastatin and Simvastatin
Status:
Completed
Completed
Trial end date:
2006-10-01
2006-10-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to compare the efficacy and safety of pitavastatin with that of simvastatin in patients with risk factors for heart disease.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Kowa Research EuropeTreatments:
Pitavastatin
Simvastatin
Criteria
Inclusion Criteria:- Males and females (18-75 years of age)
- At least two cardiovascular disease risk factors
- Must have been following a restrictive diet
- Diagnosis of primary hypercholesterolemia or combined dyslipidemia
Exclusion Criteria:
- Homozygous familial hypercholesterolemia
- Conditions which may cause secondary dyslipidemia
- Uncontrolled diabetes mellitus
- Abnormal pancreatic, liver or renal function
- Abnormal serum creatine kinase (CK) above the pre-specified level